Zhang Y, Meng R, Sha D, Gao H, Wang S, Zhou J
Front Oncol. 2024; 14:1506606.
PMID: 39697234
PMC: 11653019.
DOI: 10.3389/fonc.2024.1506606.
Septiana W, Pawitan J
Tissue Eng Regen Med. 2024; 21(8):1125-1139.
PMID: 39412646
PMC: 11589048.
DOI: 10.1007/s13770-024-00672-y.
Vitale S, Calapa F, Colonna F, Luongo F, Biffoni M, De Maria R
Adv Sci (Weinh). 2024; 11(32):e2405084.
PMID: 38962943
PMC: 11348154.
DOI: 10.1002/advs.202405084.
Katti P, Jasuja H
Polymers (Basel). 2024; 16(5).
PMID: 38475301
PMC: 10934711.
DOI: 10.3390/polym16050617.
Lin S, Wang J, Mukherjee P, Mao R, West G, Czarnecki D
Gut. 2024; 73(7):1110-1123.
PMID: 38378253
PMC: 11248270.
DOI: 10.1136/gutjnl-2022-328608.
An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis.
Au K, Wilson J, Ting J, Wang A
Nat Biomed Eng. 2023; 8(10):1243-1265.
PMID: 38049469
DOI: 10.1038/s41551-023-01136-9.
FORMATION OF MALIGNANT, METASTATIC SMALL CELL LUNG CANCERS THROUGH OVERPRODUCTION OF cMYC PROTEIN IN TP53 AND RB1 DEPLETED PULMONARY NEUROENDOCRINE CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS.
Chen H, Gardner E, Shah Y, Zhang K, Thakur A, Zhang C
bioRxiv. 2023; .
PMID: 37873210
PMC: 10592623.
DOI: 10.1101/2023.10.06.561244.
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.
Song Y, Kerr T, Sanders C, Dai L, Baxter S, Somerville B
Front Oncol. 2023; 13:1223915.
PMID: 37746286
PMC: 10516605.
DOI: 10.3389/fonc.2023.1223915.
Anti-Cancer Effect of by Targeting Metabolic Reprogramming by Regulating Gene Expression in HT-29 Human Colon Cancer Cells.
Ghodousi-Dehnavi E, Arjmand M, Akbari Z, Aminzadeh M, Haji Hosseini R
Rep Biochem Mol Biol. 2023; 12(1):127-135.
PMID: 37724146
PMC: 10505474.
DOI: 10.52547/rbmb.12.1.127.
Secreted glucose regulated protein78 ameliorates DSS-induced mouse colitis.
Zhao L, Lv Y, Zhou X, Guo Z, Li H, Guo Y
Front Immunol. 2023; 14:986175.
PMID: 36776831
PMC: 9909966.
DOI: 10.3389/fimmu.2023.986175.
Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases.
Varinelli L, Guaglio M, Brich S, Zanutto S, Belfiore A, Zanardi F
J Mol Cell Biol. 2022; 14(11).
PMID: 36460033
PMC: 10170410.
DOI: 10.1093/jmcb/mjac064.
Cancer cell survival depends on collagen uptake into tumor-associated stroma.
Hsu K, Dunleavey J, Szot C, Yang L, Hilton M, Morris K
Nat Commun. 2022; 13(1):7078.
PMID: 36400786
PMC: 9674701.
DOI: 10.1038/s41467-022-34643-5.
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile.
Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem T, Davidson B
Cancers (Basel). 2022; 14(14).
PMID: 35884597
PMC: 9325179.
DOI: 10.3390/cancers14143536.
Effectiveness of Bioinks and the Clinical Value of 3D Bioprinted Glioblastoma Models: A Systematic Review.
Leong S, Tan S, Norhayati M, Monif M, Lee S
Cancers (Basel). 2022; 14(9).
PMID: 35565282
PMC: 9103189.
DOI: 10.3390/cancers14092149.
Building gut from scratch - progress and update of intestinal tissue engineering.
Tullie L, Jones B, De Coppi P, Li V
Nat Rev Gastroenterol Hepatol. 2022; 19(7):417-431.
PMID: 35241800
DOI: 10.1038/s41575-022-00586-x.
Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology.
Abedi E, Karimi M, Yaghobi R, Mohammadi H, Haghpanah S, Moghadam M
J Clin Lab Anal. 2022; 36(4):e24289.
PMID: 35176183
PMC: 8993601.
DOI: 10.1002/jcla.24289.
Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions.
Marques-Magalhaes A, Cruz T, Costa A, Estevao D, Rios E, Canao P
Cancers (Basel). 2022; 14(2).
PMID: 35053521
PMC: 8773780.
DOI: 10.3390/cancers14020359.
Decellularized normal and cancer tissues as tools for cancer research.
Gentilin E, DAngelo E, Agostini M, Astolfi L
Cancer Gene Ther. 2021; 29(7):879-888.
PMID: 34785762
DOI: 10.1038/s41417-021-00398-2.
Modeling Metastatic Colonization in a Decellularized Organ Scaffold-Based Perfusion Bioreactor.
Rafaeva M, Horton E, Jensen A, Madsen C, Reuten R, Willacy O
Adv Healthc Mater. 2021; 11(1):e2100684.
PMID: 34734500
PMC: 11469127.
DOI: 10.1002/adhm.202100684.
Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma.
Wang G, Yang L, Gao J, Mu H, Song Y, Jiang X
Front Oncol. 2021; 11:736694.
PMID: 34692512
PMC: 8531590.
DOI: 10.3389/fonc.2021.736694.